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Background: Osteoarthritis (OA) is a common musculoskeletal disease that affects multiple 
joints. Main symptoms include pain and loss of function. The status of a patient can be 
measured by using patient reported outcome measures (PROMs). PROMs are also used to 
assess effectiveness of treatment. 
Aims: Develop a novel PROM that can assess level of function, pain and overall health in 
patients suffering from OA of the hip or knee.  
Methodology: Development was performed in four stages. For the first stage, 50 patients 
were recruited for qualitative interviews to identify activities that are affected by the 
symptoms of OA in these patients. Secondly, a group of 16 participants experienced in 
treating OA were interviewed and asked to rank items in order of relevance for assessing 
patients with OA. The third stage consisted of construction of the new PROM and a qualitative 
pre-test of the prototype with 12 patients. The highest-ranking items from each subdomain 
were used to create a list of 20 items to include in the questionnaire which was further 
supplemented by two additional questions: a body map and a VAS. A finalised list of themes 
(n=70) were ranked within their subdomains to create the new PROM. Finally, the last stage 
involved recruiting 60 patients for quantitative analysis of the new PROM for validation. 
Results: A total of 86 unique themes were identified through qualitative interviews, which 
were then grouped together as items and categorised into five domains; lower limb function, 
upper limb function, role limitation, pain symptoms and general health. Additional themes 
were identified by the expert participants. The finalised PROM consisted of 22 questions 
containing the five subdomains. Content validity was confirmed by using the methodology 
outline in the first two stages of this project. The questionnaire showed good internal 
consistency and reliability. Correlation of the new PROM against the oxford hip score, oxford 
knee score, WOMAC showed fair, moderate and strong correlations across the related 
subdomains. The new PROM showed poor correlations overall against the SF12. There were 
no identified floor or ceiling effects. 
Conclusion: From this preliminary study a variety of themes can be identified from patients 
that suffer from OA. Using themes and input from a panel of experts a prototype of the new 
PROM has been developed that can assess overall physical function, pain symptoms and 
general health. The new PROM was validated and has been shown to have good internal 
consistency and reliability. It has also correlated well against similar validated PROMS and 
shows no floor and ceiling effects. Further work is still required to complete validate the new 
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Chapter 1: Introduction 
1.1 Osteoarthritis 
1.1.1 Definition 
Osteoarthritis (OA) is a debilitating joint disease that commonly affects individuals (Litwic, et 
al., 2013). It is hallmarked by damage and degeneration of cartilage in the affected joint, with 
associated periarticular changes which include remodelling of subchondral bone, ligament 
laxity, osteophyte formation, synovitis and muscle weakness (Hutton, 1989). The most 
common joints affected are the knees, hips, and small joints in the hand (Prieto-Alhambra, et 
al., 2014). Pain is the predominant symptom of OA and it imposes a biopsychosocial burden 
on the individual (Neogi, 2013). Management of pain is the main driving force for individuals 
to seek medical care (Hadler, 1992). 
1.1.2 Epidemiology 
In the UK, over 6.5 million people have sought help for OA from their general practitioners 
(GP), and it is estimated that in patients over the age of 45 1 in 5 suffer from OA of the knee 
(Arthritis research UK). Based on work by Yu et al (2015) the annual consultation incidence of 
OA in persons ≥ 15 years of age was 8.6/1000 in men and 10.6/1000 in women. The study also 
demonstrated an increase in incidence with increasing age that peaks in the 75-84 age group. 
Based on this data it was concluded that per year a new diagnosis of OA in at risk groups was 
9 in 1000. Globally OA of the knee is responsible for approximately 85% of the burden of OA 





Historically, it was believed that OA is caused by ‘wear-and-tear’, however we now 
understand it to be a dynamic process due to imbalance between destruction and repair of 
joint tissues (Hunter, et al., 2014). This complex pathogenesis entails the interplay of 
inflammatory, metabolic and mechanical factors which ultimately leads to destruction of the 
joint (Hunter, et al., 2014). OA starts with alteration in cartilage composition and loss of 
integrity making it more susceptible to damage, which will eventually affect the deep layers 
of calcified cartilage (Leoser, et al., 2016). In an attempt to repair this damage, cells that 
maintain cartilage (chondrocytes) will increase their synthetic activity, leading to a pro-
inflammatory response that affects all the joint tissues eventually leading to the degenerative 
changes (Hsia, et al., 2018). 
1.1.4 Diagnosis 
The standard for diagnosis of OA is through clinical assessment which includes obtaining 
history of symptoms and physical examination of clinical signs. Diagnostic criteria are 
available from the American College of Rheumatism (ACR) and the European League Against 
Rheumatism (EULAR) (Altman, et al., 1986) (Zhang, et al., 2010). Radiographic criteria have 
also been created by Kellgren and Lawrence (1963), however there is limited correlation 
between clinical and radiographic signs (Hannan, et al., 2000).  
1.1.5 Treatment 
According to guidance from the National Institute of Clinical Excellence (NICE), a 
comprehensive clinical history and physical examination is recommended to assess the 
effects of OA on function, quality of life, social interaction, leisure activities and mood (NICE, 




treatment preceding pharmacological therapy as the recommended first line treatment 
(Nelson, et al., 2014). Non-pharmacological methods that have proven to be beneficial 
include physical exercise (Fransen, et al., 2015) and weight loss (Messier, et al., 2004). 
Pharmacological treatment which is recommended for OA include paracetamol and Non-
steroidal anti-inflammatory drugs (NSAIDs) (Nelson, et al., 2014).  
After exhausting non-operative treatment, patients with severe OA experiencing a decline in 
quality of life are recommended to be referred to Orthopaedic surgeons for joint replacement 
surgery (NICE, 2014). A review article by Wood et al (2013) on the management of 
osteoarthritis concluded that joint replacement surgery of the hip and knee leads to better 
quality of life, higher patient satisfaction and longevity. A way of collecting and monitoring 
data on joint replacement surgeries is through national joint registries (NJR). In the UK, 
patients undergoing elective hip or knee replacement operations funded by the NHS are 
asked to complete patient reported outcome measure (PROM) questionnaires before and 
after surgery (NHS UK, 2019). This is done to assess improvement in health from the patient’s 
perspective. 
 
1.2 Impact of OA 
The burden of OA on a person includes pain, poor quality of life, limitations in daily activity 
and disability (van der Waal, et al., 2005). The World Health Organisation has defined 
disability as an umbrella term to encompass impairment in body function or structure; 
limitation of activity in performing a task or action; and restriction in participation of a person 
in life situations (World Health Organisation). There is also a significant economic cost to OA 




1.2.1 Daily activity and disability 
OA is the most common musculoskeletal (MSK) disorder affecting elderly patients (Felson, et 
al., 1987). MSK disorders together form the 4th most common cause of morbidity (Prince, et 
al., 2015). Pain and loss of function from OA can lead to inactivity, eventually causing loss of 
quality of life (Clynes, et al., 2019). Pain, swelling and stiffness can also cause impairment in 
activities of daily living (ADL) like using computers, driving cars, walking, using stairs and 
carrying objects (Marshall, et al., 2018). 
Clynes et al (2019) have demonstrated that a diagnosis of lower limb OA in older patients is 
associated with difficulties in mobility, ability to self-care and perform ADL. Zhang et al (2002) 
found that when comparing persons with and without a diagnosis of hand OA there was a 
significant difference in functional limitation in activities involving the hand such as writing, 
gripping and using small objects. 
1.2.2 Social participation 
Social participation includes interaction in social activities, going to work and managing one’s 
home. Participation restriction is the limitation of this interaction and is proven to be related 
to poor health outcomes (Wilkie, et al., 2007). Joint pain, depressive symptoms and 
environmental barriers are associated with participation restriction reinforcing the 
biopsychosocial effects of OA (Theis, et al., 2013). 
1.2.3 Depression and anxiety 
A review by Stubbs et al (2016) looking at studies that investigated depression and anxiety in 
people with OA showed a pooled prevalence of 19.9% for depression and 21.3% for anxiety 
symptoms. The relative risk for depression and anxiety compare to those without OA were 




depression and anxiety, however it was unclear whether this proportion is increased 
compared to people without OA. 
1.2.4 Economic cost 
The economic costs of OA can be viewed as the direct cost of medical treatment and the 
indirect cost to the individual and healthcare service. It is estimated that the cost of treatment 
of OA in high-income countries like USA, UK, Canada and Australia ranges between 1 to 2.5% 
of their gross domestic product (GDP) (Hunter, et al., 2014). The indirect cost due to loss of 
productivity and loss of income are also substantial and are often overlooked when 
considering the burden of OA (Gupta, et al., 2005). In the most recent public health bulletin 
by Arthritis Research UK, the total cost of performing hip and knee replacements for Liverpool 
local authority was £5.7 million in 2011-12 (Arthritis research UK, 2019). This cost is likely to 
have increased given the trend of increasing incidence of OA. 
1.2.5 Kinetic Chain 
The kinetic chain system is a concept borrowed from engineering that is widely accepted in 
the realms of physical rehabilitation (Butler & Major, 2003). The human body can be likened 
to a linked system of rigid segments (limbs and spine) jointed together by pin joints (joints) 
(Karandikar & Vargas, 2011). When both ends of this system are fixed in place no movement 
can happen, application of an external force at one end causes transfer of force to each 
adjacent segment. The kinetic chain concept was popularised by Steindler who categorised a 
chain as either being open or closed, depending whether or not the terminal segment is fixed 
or free (Karandikar & Vargas, 2011). 
Clinical applications of the kinetic chain concept include the improvement of core stability to 




Understanding this helps explain how pathology in the hip or knee could eventually lead to 
shoulder impingement or scapular dyskinesia (Burkhart, et al., 2003). Due to this, OA of the 
hip and knee may also have an impact to overall function of a patient. 
 
1.3 Joint arthroplasty performance monitoring 
1.3.1 National joint registry 
The first joint registry that was establish was in Sweden in 1976 for knee replacements 
(Herberts, et al., 1989). This led the way in NJR and evidence-based surgery. Countries now 
with their own NJR include UK, France, Germany, Norway, Denmark and USA. 
The NJR in the UK was started in April 2003, however submission of data for NHS organisations 
only became mandatory as of April 2011. Data is collected from England, Wales Northern 
Ireland and the Isle of Man. (NJR, 2020) 
1.3.2 NJR purpose 
The NJR collects data on the type of surgery performed, implants used and method of 
implantation, PROM data and final outcome data. Currently the NJR collects data on hip, knee, 
ankle, elbow and shoulder joint replacements. This data helps to monitor the performance of 
implants and effectiveness of different operations, with the aim to improve clinical standards, 
including raising the alarm for any early warning issues relating to patient safety. (NJR, 2020) 
1.3.3 NJR Data from the UK 
NJR published the 16th annual report in 2019. Since data collection started, there are now 
2.85 million recorded entries in the registry making it the largest and most comprehensive 




performed for OA in 92% of hip replacements and 96% of knee replacements and that the 
majority of operations were performed in patients over the age of 75 years (NJR Annual 
Report, 2019). Compared to the previous year findings included a fall in revision surgery and 
an increase in the number of hip, ankle, elbow and shoulder replacements (NJR Annual 
Report, 2019). Table 1 provides a break down of total number of joint replacements 
completed list by joint. 
Table 1: Total number of replacements recorded by joint 







 *only includes entries with usable data 
 
1.3.4 PROM data 
Data collected by the NJR pertaining to the aspects of the operation are important however 
this data does not capture the outcomes of surgery from the patient perspective. This why 
the NJR also collects PROM data to obtain valuable information about the pain, mobility and 
general health of the patient following surgery. The NHS collects this PROM data before 
surgery and at six months after surgery only. But as patients’ condition may continue to 
change over a longer term the NJR has permission to continue to collect this data at one, 
three and five years after surgery. PROMs currently used in the NJR are the EuroQol 5D (EQ-






1.4 Patient reported outcome measures 
1.4.1 Definition 
PROMs are validated questionnaires that are completed by patients themselves and are used 
to measure their functional status or wellbeing (Dawson, et al., 2010). PROMs collect 
information from the patient point of view, and is useful in monitoring patient status over 
time, as in the case of joint replacement surgery. A patient would complete a PROM by 
responding to each question according to their perceived status. The responses are usually 
assigned a numerical rating or score which can then be combined to represent an overall 
score for the concept (for example pain level) being measured (Dawson, et al., 2010). 
1.4.2 PROM uses 
PROMs can be used in different ways as the information obtained is relevant to the clinicians, 
healthcare services, researchers, and patients themselves. Originally PROMs were designed 
to assess outcomes in clinical trials, they are now also used to monitor patient progress and 
evaluate treatment efficacy. PROMs are also used as a tool to measure quality improvement, 
benchmark service providers, evaluate cost effectiveness and monitor performance. As we 
have seen in the case of NJR data. For patients, PROMs help them to gain insight into their 
own condition and provides information to allow them to make informed choices in selecting 
treatment options or service providers. (Nelson, et al., 2015) 
1.4.3 NHS initiative 
In April 2009, the NHS initiated the National PROMs Programme to collect information on 
how well the health service was treating patients (NHS England, 2018). Four operations were 




groin hernia surgery. As of October 2017, PROMS collection for varicose veins and hernia 
surgery have been stopped. 
1.4.4 PROM types 
PROMs can either be generic questionnaires measuring quality of life or health in general, for 
example the Short form 36 (SF-36) which has eight subdomains that pertain to general health 
(Ware-JE & Sherbourne, 1992). And in the case of the NJR the EQ-5D. 
PROMs can also be more specific to a condition or a joint, as with the use of the Oxford hip 
score and Oxford knee scores in the NJR. 
1.4.5 PROM development principles 
The consensus-based standards for the selection of health measurement instruments 
initiative (COSMIN) is an international multidisciplinary team of researchers with expertise in 
development and evaluation of outcome measures. The COSMIN Study Design checklist 
(Mokkink, et al., 2019) is a guide to ensure that PROM development is to a recommended 
standard.  This checklist covers general recommendations for designing a PROM and 
standards to evaluate specific measurement properties or psychometric criteria (see 
Appendix A). 
Development of a robust questionnaire is a multi-step process. Firstly, the intended 
population the PROM will be used for must be defined, for example all adult patients with 
OA. Secondly, the questions used to obtain information from this group must be relevant and 
useful. Thirdly, the PROM must be tested for its validity. 
As PROMs are meant to capture information from the patient point of view, one way to 




provide a list of activities that can be converted into concepts, for example the ability to walk. 
From these concepts, questions or items can be formulated and included into a questionnaire. 
Often groups of questions will ask similar features about a common concept and these 
questions become a subdomain within the questionnaire. An example of a subdomain is the 
pain subdomain of the Western Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC). 
Once the items to be include in the PROM are decided and questions have been designed a 
duty falls on the researcher to ensure that the questionnaire is valid for use in the intended 
population (Fitzpatrick, et al., 1998) 
 
1.5 PROM examples 
1.5.1 Joint specific PROMs 
1.5.1.1 OHS 
The OHS was developed in 1996 with the intention of being a patient centred outcome 
measure to assess the benefit of treatment of hip OA (Dawson, et al., 1996). It was developed 
specifically to assess the benefit of total hip replacement in patients suffering from hip OA. 
The developers of the OHS believed that a shorter questionnaire would be more practical and 
simpler to use, and were able to demonstrate that the OHS was more sensitive in detecting 
clinical change (Dawson, et al., 1996). 
The OHS consists of 12 questions (see Appendix B). It assesses pain and function of the hip 
with regards to daily activities. Examples of concepts it investigates include walking, climbing 




possible responses based on the level of difficulty the patient has (score 1-5). The scores can 
be added together to give an overall score. (Wylde, et al., 2005) 
In its original form the OHS used lower scores to reflect better function. However, with its 
widespread use in the orthopaedic world there has been some considerable confusion in its 
application. In light of this, the originators of the OHS published recommendations of its usage 
in 2007 stating that the OHS should be scored from 0 – 48, with higher scores being better 
function. (Murray, et al., 2007) 
The main strengths of the OHS are that it is a short PROM to complete and has good reliability 
(Wylde, et al., 2005). It is also good at detecting change, and is more sensitive in this regard 
when compared to the SF-36 and the Arthritis Impact Measurement Scale (AIMS) in patients 
undergoing total hip replacements (Dawson, et al., 1996). The OHS has also been translated 
and validated into other languages including Italian (Martinelli, et al., 2011) and Danish 
(Paulsen, et al., 2012). 
1.5.1.2 OKS 
The OKS was developed in 1998 by the same research group as the OHS to assess the benefits 
of undergoing a total knee replacement (TKR) (Dawson, et al., 1998). The development team 
used the same design philosophies to develop the OKS and found that it was sensitive in 
detecting clinical change and had good reliability (Dawson, et al., 1998). 
The OKS is also a 12 item questionnaire with similar questions as the OHS and covers aspects 
of pain and level of function in regard to knee OA (see Appendix C). The recall period is 
similarly 4 weeks. As in the OHS it was originally scored on a scale of 12 – 60 but as per the 
recommendations from the original development team scoring the OKS from 0 – 48 is 




Although originally validated for patients undergoing TKR, the OKS has since been used as an 
outcome measure for other clinical studies to assess different forms of treatment for OA 
including intra-articular injection of joint lubricating supplements (Clarke, et al., 2005), knee 
realignment surgery as in high tibial osteotomy (Weale, et al., 2001) and following 
unicompartmental knee replacement (Reilly, et al., 2005). The OKS has also been translated 
for use in Sweden as part of their nation joint registry (Dunbar, et al., 2000). 
Both the OHS and the OKS are popular joint specific PROMs which are short and are sensitive 
in detecting clinical change. They are frequently used as outcome measures in clinical trials, 
clinical audits and as one of the PROMs in the NJR in the UK. (Murray, et al., 2007) 
1.5.2 Condition specific 
1.5.2.1 WOMAC 
The WOMAC is a PROM used to evaluate patients with hip or knee OA. Bellamy et al published 
two validation studies to assess the measurement properties of the WOMAC. One to establish 
its use as a PROM to assess the effects of joint replacement for hip or knee OA (Bellamy, et 
al., 1988) and the other to assess non-operative treatment of OA with NSAIDs (Bellamy, et al., 
1988). 
WOMAC has 24 questions that evaluate three subdomains: pain, stiffness and physical 
function (see Appendix D). The pain subdomain has 5 questions, stiffness has 2 and physical 
function has 17 questions. Each item in WOMAC has 5 responses (0 – 4) scaling in severity 
with higher scores indicating higher levels of symptoms or physical disability (McConnell, et 
al., 2001). The sum of the scores from each subscale can be used separately or totalled to 
derive an index score. WOMAC has also been validated so that the responses use a visual 




The WOMAC is another popular PROM to assess many treatments for patients with OA. Harris 
et al (2016) systematically reviewed PROMs used in hip and knee OA and concluded that 
WOMAC was the second most promising PROM based on the evidence available testing its 
psychometric properties as well as its development process. WOMAC has also now been used 
to assess patients with other conditions aside from OA including patients with lower back 
pain, rheumatoid arthritis and fibromyalgia (Wolfe & Kong, 1999). It has also been translated 
into other languages and validated (Wolfe & Kong, 1999). 
1.5.2.1 Michigan body map 
The Michigan body map (MBM) was developed because of inclusion of pain location the in 
Fibromyalgia Survey Criteria in 2011. The Fibromyalgia Survey Criteria is a screening tool used 
to diagnose fibromyalgia, a chronic pain syndrome.  The MBM’s aim was to further refine the 
Fibromyalgia Survey Criteria for localising areas of pain that a patient has. A point of interest 
of the MBM is that it is a graphical depiction of the human body and the patient is instructed 
to select the parts of the body (35 sites) where they experience pain. The MBM has 
demonstrated good ease of use and straightforward scoring. (Brummet, et al., 2016) 
 
1.5.3 Generic PROMs 
1.5.3.1 SF-36 
The SF-36 is a 36-item questionnaire developed to measure general health and quality of life. 
It was developed by the RAND Corporation by selecting items from a much longer 
questionnaire used in the medical outcomes study, a large multi-site study conducted in more 
than 22,000 patients to explain variations in patient outcomes (RAND Corp., 2019). SF-36 was 




between patient groups with similar health (Brazier, et al., 1992). Three aspects of general 
health that are covered by SF-36 are: functional ability, wellbeing and overall health (Patel, et 
al., 2007). 
Eight domains are covered in the SF-36: bodily pain, physical function, role limitations due to 
physical health problems, role limitations due to emotional problems, energy levels, social 
functioning, emotional well being and general health perception (Patel, et al., 2007). Scoring 
instructions for each domain can be obtained from the RAND website, which gives a weighted 
score or each domain from 0 – 100, with higher scores indicating better health (RAND Corp). 
A modified scoring method is also possible which derives a physical component summary 
(PCS) and a mental component summary (MCS) from  the 8 domain scores, but this method 
requires ample population data as it is adjusted by the population mean and standard 
deviation (Patel, et al., 2007). 
SF-36 is used across many different medical conditions including angina and renal dialysis 
(Marquis, et al., 1995) (Meyer, et al., 1994). SF-36 has also been used assess health status, 
determine treatment effectiveness, compare different treatments for different types of 
orthopaedics conditions (Patel, et al., 2007). 
1.5.3.2 SF-12 
The SF-12 uses a subset of questions from SF-36 to create a shorter 12-item questionnaire 
that is believed to derive similar measures of PCS and MCS while taking a shorter amount of 
time to complete (Ware, et al., 1996). Two items from the physical function, mental health 
and the physical and mental role limitation domains of the SF-36 are used to make  up 8 




levels, social function and general health) make up the remaining four (see Appendix E) (Ware, 
et al., 1996).  
SF-12 uses proprietary owned scoring algorithm to obtain the PCS and MCS, also based on 
population mean scores (Ware, et al., 1995). A study by Jenkinson et al (1997) demonstrated 
that the PCS and MCS scores of SF-12 and SF-36 in three separate population groups (heart 
failure, sleep apnoea and inguinal hernia surgery) were virtually identical. Based on this the 
SF-12 may be the PROM of choice in certain scenarios given its shorter completion time, 
however, as only one or two items are used for each original subscale this limits the precision 
of the SF-12 (Patel, et al., 2007). 
1.5.3.3 EQ-5D 
The EQ-5D was established by the EuroQol Group in 1987 as a generic outcome measure to 
assess health-related quality of life in a patient. It consists of five domains which are: mobility, 
self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain can be 
answered using a three-level system: no problems, some problems, severe problems. The 
combination of responses from the five domains allows for 243 unique health states. There is 
also a visual analogue scale for self-assessment of one’s state of health on a scale from 0 – 
100. The EQ-5D was developed as a supplementary tool to be used alongside other PROM. 





1.6 Questionnaire validation 
Validation of a questionnaire ensures that the questionnaire measures what it intends to 
measure (Polit & Beck, 2006). As reviewed by Gagnier et al. (2017), a PROM should satisfy 
certain psychometric criteria to confirm its validity. There are different types of validity which 
include content validity, reliability and accuracy, and criterion validity. 
1.6.1 Content validity 
For content validity, qualitative analysis of structured interviews with patients and opinions 
from a panel of experts in the field can generate a list of relevant items. The items selected 
by this process would confirm the content validity of the questionnaire. 
1.6.2 Reliability 
To be trusted a questionnaire needs to be reliable. This means that repeating the 
questionnaire within a suitable timeframe, for instance within two weeks, should produce the 
same results providing that there have not been any significant changes with the condition of 
the patient. To assess reliability the correlation or level of agreement between the results of 
two questionnaires filled in by the same patient at different times can be measured 
(Bolarinwa, 2015). 
1.6.3 Internal consistency 
Within the questionnaire, items grouped together should all aim to measure the same 
concept. This can be confirmed by measuring the internal consistency of the questionnaire or 
its individual subdomains. A method of measuring this is to use Cronbach’s alpha coefficient, 




internal consistency. If internal consistency is found to be low then items can be sequentially 
removed until the best Cronbach’s alpha coefficient is derived. (Cho, 2016) 
1.6.4 Criterion validity 
Criterion validity aims to confirm whether information obtained from a PROM can predict the 
true status of a patient (Liang, et al., 2014). In other words, this is the accuracy of a 
questionnaire. This form of validity requires a ‘gold standard’ to measure against. Criterion 
validity in the clinical setting is difficult to measure as the perception of pain and physical 
function are subjective concepts with no true gold standard test to compare against. Accepted 
methods off confirming criterion validity are to measure correlations against other PROMs 
which are intended to measure the same or similar concepts. If the new PROM can 
demonstrate good correlation with other established PROMs, then it can be considered to 
have satisfactory criterion validity.  
Subtypes of criterion validity include convergent and divergent validity, which aim to confirm 
correlation between similar concepts and no correlation between unrelated concepts 
respectively. 
1.6.5 Floor and ceiling effects 
The total scores from a questionnaire may sometimes demonstrate floor and/or ceiling 
effects. This means that a higher than acceptable proportion of patients are reporting either 
the maximum or minimum score. This could indicate that the patient is not able to express 
their level of status which may exist beyond the confines of the questionnaire. Acceptable 
limits of floor and ceiling effects are 15% of total scores. This can be calculated by measuring 




1.6.6 Sensitivity to detect change 
When a patient is subjected to an intervention, their status may change. A change in status 
can be reflected by a difference in scores of a questionnaire completed before and after the 
intervention. For example, the difference in pain scores before and after joint replacement 
surgery should be statistically different (McQuay, 2004). In validating a questionnaire for 
sensitivity, the effect size can be measured statistically. The minimum clinically important 
difference is a concept of measuring sensitivity in clinical practise (King, 2011). 
1.6.7 Patient burden 
Aside from satisfying the above psychometric criteria, other aspects that make a 
questionnaire suitable for use include its ease of delivery, time required to complete, and 
level of comprehension needed to answer the questions. All these factors reflect a burden on 
the patient. For a questionnaire to be effortless to complete it should be simple in its 





1.7 Research Methods 
As already mentioned, the development of a PROM is a multi-step process. To that end 
different types of research methods must be used for different stages of the development 
process. Broadly, there are two general methods of obtaining data; qualitative and 
quantitative. There is also a mixed method approach which incorporates both elements 
today. In terms of this project, either qualitative or quantitative methods will be used 
exclusively for a particular stage. 
1.7.1 Qualitative Research 
The process of designing a questionnaire requires understanding of the population being 
observed. Qualitative research is a useful method of obtaining data pertaining to the patient 
experience, through a systematic analysis of textual material obtained from talk or 
observations (Malterud, 2001). By exploring these experiences, the researcher can begin to 
develop an understanding behind the motivations and beliefs of the observed population, 
and through interpretation of these findings one is able extract points of view that may be 
more common to that population (Malterud, 2001).  
One way to obtain data through qualitative research is through interviews with the study 
participants. Common themes and underlying ideas and experiences can then be observed 
from analysis of these interviews. There are several different types of established qualitative 
research approaches; case-study, ethnography, grounded theory, and phenomenology 
(Grossoehme, 2014). This study will apply phenomenology research as its qualitative research 
approach to explore patient experiences living with OA and the limitations they observe in 





The common themes extracted through this qualitative research will be used as the basis of 
a conceptual framework to guide the development process of designing a novel PROM. This 
PROM will then be assessed for its validity through psychometric analysis. 
1.7.2 Quantitative Research 
Quantitative research involves the gathering and analysis of numerical data. There are four 
different types of quantitative research: descriptive, correlational, casual-comparative and 
experimental. (Creswell, 2009) 
The quantitative research involved in validation of a PROM will mainly fall into the descriptive 
and correlational types, as the data obtained will be used to test the robustness of the PROM 






1.8 Project Rationale 
PROMs have their merit in the clinical setting in facilitating our understanding of certain 
conditions from the point of view of the patients. As it currently stands the NJR in the UK is 
actively utilising PROMs to capture patient reported data to measure outcomes of joint 
arthroplasty. As already mentioned, patient undergoing hip or knee arthroplasty are given a 
battery of PROMs to complete in one sitting (NJR, 2020), this can become a burden for the 
patient due to the time it takes to complete these PROMs. 
Part of the reason why multiple PROMs are used is due to the inherent limitations for the 
joint specific PROMs to capture data regarding comorbidities that way be a contributing factor 
in a patient’s loss of function or disability (Lim, et al., 2006). It has also been recognised that 
aside from the physical limitations due to pain, OA can also have social and psychological 
impacts on patients (Wilkie, et al., 2007) (Theis, et al., 2013). 
This project proposes to design a novel PROM that will aim to reduce patient burden by 
creating a condition specific PROM that will assess patients’ overall level of function in the 
context of suffering from OA. The project will also attempt to incorporate alternative methods 
of questioning (VAS and a body map) to gauge a patient’s insight into their level of function 
and to graphically localise where they are having pain. For such a PROM to be suitable for use 
in the scope of our clinical practise it should then be validated to satisfy the previously 








“To design a patient reported outcome measure designed for patients with lower limb 
osteoarthritis that can assess their level of global function, level of pain and overall general 






• Define the population of patients the PROM will be developed for. 
• Recruit patients to qualitatively explore symptoms, aspects and activities that are 
affected by OA. 
• Recruit expert participants to qualitatively assess features of OA and the functional 
limitations that are caused by it. 
• Design a novel PROM based on information obtained from recruited participants. 
• Preliminary test of PROM to qualitatively ascertain ease of use. 





Chapter 2: Methodology 
2.1 PROM design outline 
Development of the PROM was performed in four stages. 
First stage 
Derive a list of themes related to the effects of osteoarthritis in the target population which 
would then become the basis for creating questions (items) in the new PROM. 
Second Stage 
Recruit a panel of experts to provide additional themes that can potentially be included into 
the questionnaire and to ask them to rank all the included themes in order of priority. 
Third Stage 
Construction of the new PROM by selecting themes to create items and to include a body 
map of joint pain and a VAS for patient satisfaction. A qualitative pre-test will be conducted 
in this stage before the final version of the PROM is validated. 
Fourth Stage 
Validation of the questionnaire according to the various psychometric criteria already 
mentioned. A flow chart of the stages is depicted in the following figure (Figure 1) 
All statistical calculations were performed using IBM SPSS Statistics for Windows (Version 






Figure 1: Flow chart of questionnaire creation 
 
Each stage was regarded as an independent step in the project. A new sample of participants 
were recruited to complete each stage. Each participant was informed about the project 
objectives in general and more specifically about the stage they would be involved in. 
Participation was voluntary and informed consent was obtained from each participant. A 
summary of the number of participants recruited is shown in the following figure (n = number 












2.2 Patient recruitment 
The patients were recruited from orthopaedic clinics and wards at Broadgreen Hospital (Royal 
Liverpool and Broadgreen University Hospitals Trust). The inclusion criteria were adult 
patients suffering from OA of the hip or knee that were being offered joint replacement 
surgery. The reason for selecting these patients was that end stage OA would represent a 
relatively stable state of the disease where there would be limited variability in day to day 
symptoms. Patients were recruited for the item generation, prototype pretesting and 
validation stages of the PROM development. Patients that participated were given printed 
information sheets about the stage of the project (see Appendix F) and written consent was 
obtained and recorded on consent form (see Appendix G).  
 
2.3 Health professional recruitment 
The health professionals consisted of orthopaedic consultants, senior orthopaedic trainees, 
and physiotherapists with experience in managing patients with OA. This group formed a 
panel of experts that were recruited for the stage of item selection for the PROM. All 
participants were employed by the Royal Liverpool and Broadgreen University Hospitals Trust 
and worked in the same clinics that the patients were recruited from. Information about the 
project was given and consent was obtained for their participation (see Appendix H). Expert 





2.4 Ethical approval 
Ethical approval was obtained from the Health Research Authority (NHS England) to 
undertake this project (Appendix I). This project was sponsored by the University of Liverpool. 
The researchers involved in this project have completed an Introduction to Good Clinical 
Practice (GCP) eLearning module organised by the National Institute for Health Research, 





2.4 Development stage 1 
2.4.1 Patient Demographics 
The inclusion criteria for the participants of this stage of the project were: 
1. Patient over the age of 18 years old 
2. Has an established diagnosis of OA of at least one hip or knee knee 
The following table (Table 2)summarises details of the patient participants recruited for this 
stage of the project. 
Table 2: Summary statistics for participants in stage 1 
Summary Statistic Value 
Number recruited 50 
Mean age (years) (sd) 66 (11.39) 
Male:Female ratio 23:27 
BMI (Kg/M2) (sd) 31 (5.3) 
 
The following table (Table 3) summarises the primary joints affected by OA in this sample of 
patients. The patients have been listed based on the total number of joints affected by OA 
regardless to treatment that has be given. Objective information regarding the joints involved 
was obtained from electronic clinical records of the patients and recorded on the participant 
data collection sheets. 
Table 3: Summary of joints affected by OA 
Joints affected Number of Patients 
Both hips and knees 18 
Bilateral hip joints 8 
Single hip joint 9 
Bilateral knee joints 10 






2.4.2 Qualitative data collection 
Semi-structured interviews were conducted by two researchers (HY & AM). An interview 
guide was used to maximise diversity in patient responses (Appendix K). The minimum 
number of patients to be recruited for this stage was set at 50. By interviewing this number, 
it was believed that the majority of aspects pertaining to the effects of OA would be explored 
and this would ensure questions included in the PROM would satisfy content validity. Patient 
responses were transcribed onto data collection sheets during the interview (see Appendix 
L). 
2.4.3 Qualitative data analysis 
Information collected from each interview was analysed and recorded in Excel (Microsoft). 
Findings that described a reduction of functional ability or activities that were limited due to 
patients’ symptoms were identified and highlighted as themes. Other concepts that were 
considered important and were also included were patient symptoms, general health, and 
social interactions. These themes were then grouped into categories which were then used 





2.5 Development stage 2 
Initially, the panel of experts were interviewed to identify concepts that they felt suitably 
measured the level of physical function from a clinician’s perspective. This was to confirm that 
the themes identified were relevant for the clinician and to ascertain if any other concepts 
were missed from the interviews with the patients. 
To rank the themes, the panel of experts completed questionnaires which listed all the 
themes grouped in their subdomains. The participants were asked to comment on how 
strongly they agreed or disagreed on the importance of each being used as a concept to assess 
the subdomain it belonged to. Responses were recorded using a Likert scale which were given 
numerical values for statistical analysis (value = 1-6) (see Appendix M). Two rounds of 
questionnaires were conducted. Themes with the low average scores were eliminate in 
between the first and second rounds. The expert panel were made aware of the results of the 
first round prior to conducting the second round. The highest scoring themes from the second 





2.6 Development stage 3 
2.6.1 Item selection 
In creating the PROM from the list of themes the first thing to consider was the length of the 
questionnaire. To reduce patient burden only 20 questions were included. The selection of 
items for the final questionnaire was made by the research team as guided by the opinions of 
the expert panel. All of the five subdomains identified were included.  
The number of items for each subdomain were not the same and more questions were 
included for the subdomains pertaining to physical function. This was done intentionally to 
allow for a PROM that was weighted towards assessing physical function but was still able to 
provide a reasonable reflection of the patient’s social role limitation, pain symptoms and 
general health. 
With regards to the design of each question it was felt that using a Likert type scale with five 
responses would be the most appropriate in terms of ease of answering the questions. For 
each item, the research team assigned a score from zero to four, higher values indicating 
better levels of functional ability. These values were assigned to aid in statistical analysis and 
to provide an overall score for the questionnaire. 
2.6.2 Body map and VAS 
A body map was created by the researchers using Powerpoint (Microsoft) as an original 
graphic to represent the human body. Boxes were included over the main joints for patient 
to place numbers in accordance with severity of pain experienced in that joint. The VAS scale 
was constructed as a horizontal line (10 cm) with equidistant markings at each 1cm to 




of function on this scale. The researcher is then able to measure where the mark in placed in 
mm to obtain the patients’ level of satisfaction as a percentage. 
2.6.3 Qualitative pre-test 
Table 4: Summary Statistic for participants in Stage 3 
Summary Statistic Value 
Number recruited 12 
Mean age (years) (sd) 70 (7.15) 
Male:Female ratio 4:8 
 
Patients were given the prototype questionnaire to complete, and a short interview was 
conducted afterwards. Patient were recruited from the Orthopaedic wards on the day there 
were to have their joint arthroplasty surgery. The follow table summarises the participant 
demographics. An interview guide (Appendix N) was used to ensure that the research team 
enquired about the clarity of instructions, how easy it was to complete, and whether there 
were any questions that were unnecessary or left out from the questionnaire. The aim was to 
gather opinion on whether the PROM covered all relevant aspects to assess physical function. 
Patients were also encouraged to comment on anything that was unclear or confusing. 
Patients were also presented with three formatting styles for the questionnaire and were 
asked to choose a preference. The style that received the most votes would be used as the 












2.7 Development stage 4 
2.7.1 Patient recruitment 
Patients were recruited from Orthopaedic clinics at Broadgreen Hospital (Royal Liverpool and 
Broadgreen University Hospitals Trust) on the day that they were listed for joint arthroplasty 
surgery. As a routine these patients would be asked to complete PROMs required by the NJR. 
Recruited patients were asked to complete the novel PROM along side these PROMs. Patients 
were then given a stamped envelope with another copy of the novel PROM inside, and were 
instructed to complete and return it after 48 hrs. The following table (Table 5) summarises 
the patient demographics and the numbers used during each validation step. 
Table 5: Summary Statistics for participants in Stage 4 
Summary Statistic Value 
Number recruited 60 
Mean age (years) (sd) 69 (11.05) 
Male:Female ratio 30:30 
BMI (Kg/M2) (sd) 30.5 (4.7) 
Validation Step Number 
Internal Consistency 60 
Test-Retest 47 
Correlation: OHS 27 
Correlation: OKS 33 
Correlation: WOMAC 60 
Correlation: SF12 60 
Floor and Ceiling 60 
 
2.7.2 Validation 
Patients recruited into this stage were given the newly developed PROM as well as the Oxford 
hip or knee score, WOMAC and SF-12 questionnaires to complete in clinic. Patients were then 




again by the patient after 48 hours. The envelopes were already stamped and addressed to 
the primary research site. Data obtained from the questionnaires were used to test validity. 
2.7.3 Internal consistency 
Internal consistency of the PROM was measured statistically by Cronbach’s Alpha. Cronbach’s 
alpha is widely used to measure internal consistency among items within a questionnaire by 
investigating the interrelatedness of all the items within a presumed scale of subscale (Taber, 
2018). It is measured by splitting the items of a scale into half and calculating the correlation 
between the two halves, so called split-half coefficient, the Cronbach’s alpha is the factor of 
all split-half coefficients of that scale (Taber, 2018). Cronbach’s alpha is presented as a 
number between 0 and 1, with alphas closer to 1 showing higher internal consistency. 
Separate analysis was performed on the first 20 questions and on each subdomain. 
Calculation of Cronbach’s Alpha was also performed on each subdomain with sequential 
deletion of each item to investigate if this would improve internal consistency. As the body 
map and VAS were standalone questions internal consistency was not performed. 
2.7.4 Test-retest reliability 
To assess reliability, interclass correlation coefficient (ICC) was perform between the PROM 
completed on the day of recruitment and the PROM that was returned to the researchers 
after 48 hours. ICC was calculated for each item individually, for the total scores of each 
subdomain and also for the total score of the first 20 questions. The two-way mixed effects 




2.7.5 Criterion validity 
To test for criterion validity of the new PROM the total scores derived from each subdomain 
were correlated against the Oxford hip or knee score, WOMAC and SF12. Where possible, 
convergent and divergent validity was assessed by comparing similar and unrelated 
subdomains respectively. 
Descriptive statistics were performed individually for each of the PROMs to assess the pattern 
of distribution of the data set. As the total scores of the subdomains created a continuous 
scale, statistically they could be compared to the scales produced from the OHS, OKS and 
subscales of WOMAC. If the data was found to be parametric then Pearson’s correlation 
coefficient was used for correlation analysis. For non-parametric data, Spearman’s rank 
correlations were obtained. For the body map Spearman’s rank correlation was used. Lastly, 
Pearson’s correlation coefficient was used to compare the VAS question. 
2.7.4.1 Oxford hip and knee score comparison  
The recruited patients with either knee or hip OA were divided into two groups depending on 
the affected joint. Analysis of the two groups was undertaken separately. All subdomains from 
the new PROM were compared to the respective Oxford score. This was done to allow testing 
for convergence and divergence of themes. It was decided that Spearman’s rank correlation 
coefficient would be used because of the data distribution. 
2.7.4.2 WOMAC comparison 
Only the pain and physical function subdomains of WOMAC were used for comparison. The 
pain subdomains from the new PROM and WOMAC were compared. For the physical function 





As the body map did not have a direct comparison in other PROMs, validating this question 
was done by treating it as a surrogate measure for pain. Thus the body map numerical score 
was correlated against the WOMAC pain subdomain. 
2.7.4.3 SF12 comparison 
The physical function composite (PCS) score was correlated against the lower limb function, 
upper limb function and role limitations subdomains of the new PROM. The mental health 
composite score was correlated against the general health subdomain as this assesses the 
effects of patients’ mood and general health on their physical function. 
As VAS score reflected the level of satisfaction of patients with their level of function and it 
was felt that the mental health composite score of the SF12 was best suited to assess criterion 
validity for this question. 
2.7.6 Floor and ceiling effects 
To test for floor and ceiling effects the total scores of each subscale and the total score of the 
first 20 questions were analysed for frequency of the minimum and maximum possible scores 
using the results from PROM completed by the patients on the day of recruitment. Floor and 





Chapter 3: Results 
3.1 Development stage 1 
3.1.1 Qualitative data collection 
The number of patients recruited to this stage was 50. The mean (±sd) age was 66 (±11.39), 
of which 27 (54%) were female.  All patients were interviewed by the research team and a 
data collection sheet was used to record relevant information including the primary joint 
affected by OA, previous treatment(s), and other medical problems. An interview guide was 
used to prompt the researcher with open ended questions to ascertain aspects of daily 
function that were affected by the patient’s condition. These ideas and concepts were 
transcribed onto the data collection sheets. 
3.1.2 Qualitative data analysis 
A total of 86 unique themes were identified. The frequency of each unique element was 
determined. Themes that were mentioned included physical activities patients found difficult, 
social activities and symptoms related to OA or other medical problems. The most frequent 
theme that was mentioned was ‘walking’ (82%). This was followed by ‘using stairs’ (48%) and 
‘getting in and out of cars’ (38%). A list of the twenty most frequent themes identified are 
listed in Appendix O. 
Each theme was then evaluated and converted into a single word or short phrase so that 
similar themes could be grouped together. For example, ‘difficulty in getting in or out of a car’ 
and ‘difficulty getting on or off a bus’ were rephrased as ‘difficulty entering or exiting a 














3.2 Development stage 2 
3.2.1 Expert participants 
Sixteen expert participants were recruited for this stage of development. The panel consisted 
of orthopaedic consultants, clinical fellows, senior registrars and senior physiotherapists 
(Table 3). 
Table 6: Breakdown of expert panel 
Expert participant Years of experience 
Position Number Mean (SD) 
Orthopaedic Consultant 6 21.83 (7.68) 
Senior clinical fellow 3 9.33 (1.15) 
Senior registrar 2 7.50 (3.54) 
Physiotherapist 5 22.60 (8.62) 
Total 16 17.94 (9.12) 
 
3.2.2 Qualitative interviews with expert panel 
Eight new themes were identified and were added to the existing pool of potential items that 
would be included in the final questionnaire (Table 4). 
Table 7: List of new items added 
New item description Subdomain 
Maximum walking distance 
Lower limb function 
Squatting 
Standing for a period of time 
Standing on tip toes 
Walking on uneven surfaces 
Gait abnormality 
Walking stability 
Walking up and down hills 
Stopping activity because of pain 
Pain and symptoms 






3.2.3 Expert participant opinion 
For the first round of questionnaires the response rate was 87.5%. Items which had a mean 
score greater than 5 where thought to be highly desirable for inclusion in the final 
questionnaire. If more than 70% of the participant responses were within the 95% confidence 
interval of the scores then it was decided that there was consensus for that item response. 
Appendix P contains completed statistics of this stage. Items with a mean score of less than 4 
were thought to be undesirable and were removed from the pool. Only one item, ‘standing 
on tip toes’, was removed after the first round. A summary of the results was given to the 
expert panel prior to commencing the second round. 
The response rate for the second round was 62.5%. All items that were desirable from the 
first round maintained a mean score above 5, and there was still consensus among the 
remaining participants for each of these items. Given that there was stability in the responses 
between the first and second rounds a further round was felt to be unnecessary. Following 
this process, the items that were identified as being desirable were added to the item bank 






3.3 Development stage 3 
3.3.1 Questionnaire outline 
The final version of the questionnaire included 22 questions: 20 questions derived from the 
item bank using Likert type responses, the body map and the VAS. The following table details 
how many questions were allocated to each subdomain. (Table 5) 
Table 8: Number of questions included for each subdomain 
Subdomain Number of questions 
Lower limb function 6 
Upper limb function 5 
Role limitation 4 
Pain and symptoms 3 
General health 2 
 
3.3.2 Question design 
3.3.2.1 Lower limb, upper limb and role limitation 
The lower limb function, upper limb function and role limitation subdomains where grouped 
together as the same Likert scale could be used. This section of the questionnaire started with 
instructions for the patient asking them to select a single response that best describes their 
average level of function. The recall period was for one month.  
The five-point scale was scored from 0 to 4. The scale consisted of options that would indicate 
no difficulty in performing an activity (score 4) at one end and unable to perform the activity 
(score 0) at the other, increments in between these extremes would increase in level of 
difficulty performing the activity. This was then followed by a prompt ‘when I need to’ before 
listing included items from the three subdomains. The following figure demonstrates how the 





Figure 5: Instructions and scale used for first 15 questions in PROM 
 
3.3.2.2 Pain and symptoms 
The questions were split into two sections. The first section instructed patients to select which 
response best describes pain at rest. Here the five-point scale was used to indicate increasing 
levels of pain from no pain at rest (score 4) to constant pain (score 0). The second section 
asked how pain would affect the patient’s overall function when trying to use either their 
arms or legs with a scale that indicated no limitation (score 4) to complete limitation (score 
0). The next figure shows how the pain symptom questions are laid out in the PROM (Figure 
6). 
 






The general health subdomain used the same scale as in the second section of the pain 
subdomain however two individual questions were asked. Examples were included in the final 
version of the PROM to provide more clarity to the questions (Figure 7). 
 





3.3.2.4 Body map 
The body map consisted of a figure of a human with boxes overlying the main joints of the 
body (Figure 8). Instructions were given to the patient to fill in the boxes with numbers (0-10) 
to indicate the amount of pain they experience from that particular joint. 
 






This question instructed the patient to mark along the scale their level of satisfaction with 
their overall level of function.  
 
Figure 9: VAS question 
 
 
3.3.3 Item inclusion 
3.3.3.1 Lower limb function 
The items included in this subdomain were activities which would gauge a patient’s level of 
lower limb function. Because of the format of the questionnaire the activities only needed to 
be listed as per the following table. (Table 6) 
Table 9: Included items in lower limb function subdomain 
Activity to be performed by the patient 
1. Stand up from a chair 
2. Put on footwear 
3. Get in and out of a car 
4. Walk for 10 minutes 
5. Go up a flight of stairs 





3.3.3.2 Upper limb function 
Like the lower limb function subdomain, the activities listed would gauge the patient’s upper 
limb function and are listed in the following table. (Table 7) 
Table 10: Included items in the upper limb function subdomain 
Activity to be performed by the patient 
1. Carry things (e.g. shopping bag) 
2. Do up buttons 
3. Reach for something at shoulder height 
4. Turn a key 
5. Prepare a meal 
 
3.3.3.3 Role limitations 
This subdomain included activities that considers a person’s interaction in society and 
activities that require whole body function to complete. Table 8 lists the activities that were 
included in the questionnaire. 
Table 11: Included items in role limitations subdomain 
Activity to be performed by the patient 
1. Do my regular job or daily routine if retired 
2. Perform leisure or sporting activities 
3. Do housework 
4. Go shopping on my own 
 
3.3.3.4 Pain and symptoms 
The pain and symptoms subdomain first elicit the patient’s level of pain at rest. This is 
followed by two questions that asks how pain limits the patient’s overall function when trying 




3.3.3.5 General health 
The general health subdomain uses the two remaining questions to assess whether a patient’s 
overall level of function is affected by other factors aside from their joint disease. The general 
health subdomains aim to elicit whether a patient’s general medical health or their mood 
cause limitations to their overall level of function. 
3.3.4 Qualitative pre-test 
For pre-testing, twelve patients were recruited. The mean (±sd) age was 68.92 (±7.15) years, 
with seven male and five female patients. Nine of the patients were about to undergo a total 
knee replacement and the remaining three were due to have a total hip replacement. 
Eleven (91.6%) of the patients commented that the PROM was easy to fill in and that 
assistance was not required. The one patient who needed help was assisted by her husband, 
and this was due to her having poor vision. Eight of the patients commented that the 
questions in the PROM were relevant. Only two questions were felt to be missing and these 
were ‘getting in and out of a bath’ and ‘standing for long periods of time’. Other general 
comments regarding the clarity of the questionnaire included the use of examples for medical 
conditions and mood (general health subdomain) and rewording of some of the instruction 
to make them clearer. 
With regards to general format of the questionnaire three format styles were presented to 
the patient. Patients were asked to comment on which format was most aesthetically 





Table 12: Popularity of each format style 
Format style Number of votes 
Table 7 




The most popular style (table style) was selected as the format for the finalised questionnaire. 
Given that the majority of the patients felt that the questions included were all relevant none 
of the items were changed and only minor adjustments were made to for the sake of clarity. 





3.4 Development stage 4 
3.4.1 Patient recruitment 
The number of patients recruited for this stage was 60, mean (±sd) age was 69.03 (±11.05), 
30 female and 30 males. 
3.4.2 New PROM validation 
Statistical analysis for internal consistency was completed using data from the new PROM 
completed on day of recruitment. Test-retest reliability was completed by using complete 
PROM on recruitment day and returned PROMS. Analysis for criterion validity was completed 
using data from questionnaires completed by patients on day of recruitment. Missing data 
has been acknowledged and addressed in the relevant sections where necessary. 
3.4.3 Internal consistency 
Results from the new PROM completed on day of recruitment were used (n=60). The 
Cronbach’s alpha, item mean (±sd) and mean (±sd) total score (scale) for each subdomain are 
displayed in the following table (Table 10). A Cronbach’s alpha value greater than ‘0.70’ is 





Table 13: Summary of Cronbach’s Alpha and means for first 20 questions in new PROM 
New PROM Cronbach’s Alpha Item mean (sd) Scale mean (sd) 
Question 1 – 20 0.93 2.23(0.84) 44.55(13.61) 
Subdomain Cronbach’s Alpha Item mean (sd) Scale mean (sd) 
Lower limb function 0.81 1.73(0.20) 10.35(4.25) 
Upper limb function 0.87 3.08(0.65) 15.40(4.23) 
Role limitation 0.81 1.61(0.47) 6.43(3.68) 
Pain and symptoms 0.52 2.07(1.15) 6.22(2.01) 
General health 0.74 3.08(0.22) 6.15(1.94) 
 
Cronbach’s Alpha for the first 20 questions suggests high internal consistency within the new 
PROM. Analysis of the subdomains also showed good internal consistency apart from the pain 
and symptoms subdomains. The following tables demonstrate Cronbach’s Alpha for each 
subdomain, as well as the Cronbach’s Alpha after sequential deletion of items from the 
related subdomain. (Table 11 - 14). 
Table 14: Cronbach’s Alpha for Lower limb function subdomain if item deleted 
PROM question number Cronbach’s Alpha if item deleted 
Question 1 0.76 
Question 2 0.80 
Question 3 0.76 
Question 4 0.80 
Question 5 0.77 
Question 6 0.79 






Table 15: Cronbach’s Alpha for Upper limb function subdomain if item deleted 
PROM question number Cronbach’s Alpha if item deleted 
Question 7 0.89 
Question 8 0.81 
Question 9 0.82 
Question 10 0.84 
Question 11 0.84 
Cronbach’s Alpha for Lower limb function subdomain = 0.87 
 
Table 16: Cronbach’s Alpha for Role limitation subdomain if item deleted 
PROM question number Cronbach’s Alpha if item deleted 
Question 12 0.77 
Question 13 0.81 
Question 14 0.71 
Question 15 0.77 
Cronbach’s Alpha for Lower limb function subdomain = 0.81 
 
Table 17: Cronbach’s Alpha for Pain and symptoms subdomain if item deleted 
PROM question number Cronbach’s Alpha if item deleted 
Question 16 0.55 
Question 17 0.20 
Question 18 0.53 
Cronbach’s Alpha for Lower limb function subdomain = 0.52 
 
Item deletion was not performed for the general health subdomain as there were only two 
items in this subdomain. 
3.4.4 Test-retest reliability 
Thirteen patients did not return the second questionnaire after 48hr giving a response rate of 
78.33%. This missing data was handled statistically with listwise deletion (Roth, 1994) and 
therefore the sample size was reduced to 47. The following table lists the ICC for each item in 





Table 18: Interclass correlation coefficient for each question in new PROM 
Question/Subdomain ICC (N=47) 95% Confidence Interval 
(Lower limb function)   
Question 1 0.73 0.52 – 0.85 
Question 2 0.86 0.75 – 0.92 
Question 3 0.84 0.72 – 0.91 
Question 4 0.83 0.69 – 0.90 
Question 5 0.77 0.60 – 0.87 
Question 6 0.73 0.51 – 0.85 
Subdomain scale 0.88 0.78 – 0.92 
(Upper limb function)   
Question 7 0.80 0.64 – 0.89 
Question 8 0.78 0.60 – 0.88 
Question 9 0.85 0.73 – 0.92 
Question 10 0.72 0.49 – 0.84 
Question 11 0.82 0.68 – 0.90 
Subdomain scale 0.88 0.79 – 0.94 
(Role limitation)   
Question 12 0.74 0.54 – 0.86 
Question 13 0.78 0.60 – 0.88 
Question 14 0.82 0.67 – 0.90 
Question 15 0.88 0.79 – 0.94 
Subdomain scale 0.87 0.76 – 0.93 
(Pain and symptoms)   
Question 16 0.80 0.64 – 0.89 
Question 17 0.71 0.48 – 0.84 
Question 18 0.61 0.31 – 0.78 
Subdomain scale 0.80 0.64 – 0.89 
(General health)   
Question 19 0.82 0.68 – 0.90 
Question 20 0.88 0.78 – 0.93 
Subdomain scale 0.88 0.78 – 0.93 
Question 1 – 20 scale 0.92 0.86 – 0.96 





3.4.5 Criterion validity 
3.4.5.1 New Prom data distribution 
Plotting histograms of each scale subdomain obtained from the new PROM (n=60) suggested 
that the data obtained was not normally distributed (Figure 10). As a numerical score was 
assigned to each ordinal response in the first 20 questions a continuous integer scale can be 
obtained, however as the responses are based on ordinal data and the histograms displayed 












3.4.5.2 Oxford hip score comparison 
Twenty-seven patients were assigned to this group. The following figures demonstrate scatter 
plots of the OHS against the five subdomains of the new PROM (Figure 11).  Line of best fit 
was included along with 95% confidence intervals. The Spearman’s rank correlation 














Table 19: Summary of Spearman’s Rank Correlation for OHS and new PROM 
Subdomain Correlation Coefficient Significance Level 
Lower limb function 0.65 <0.05 
Upper limb function 0.79 <0.05 
Role limitation 0.77 <0.05 
Pain and symptoms 0.74 <0.05 
General health 0.64 <0.05 
 
Upper limb function and role limitation subdomains of the new PROM demonstrated strong 
correlation with the OHS. Lower limb function, pain and symptoms and general health 





3.4.5.3 Oxford knee score comparison 
Thirty-three patients were assigned to this group. Similar to the OHS, the following figures 
demonstrate scatter plots of the OHS against the five subdomains of the new PROM (Figure 
12).  Line of best fit was included along with 95% confidence intervals. The Spearman’s rank 













Table 20: Summary of Spearman’s Rank Correlation for OKS and new PROM 
Subdomain Correlation Coefficient Significance Level 
Lower limb function 0.77 <0.05 
Upper limb function 0.61 <0.05 
Role limitation 0.70 <0.05 
Pain and symptoms 0.75 <0.05 
General health 0.44 <0.05 
 
Lower limb function and pain and symptoms subdomains of the new PROM demonstrated 
strong correlation with the OKS. Upper limb function and role limitation subdomains showed 
moderate correlation with the OKS. Only weak correlation was demonstrated from the 






3.4.5.4 WOMAC comparison 
Pain subdomain 
Sixty patients were included in analysis of the pain subdomains. The Spearman’s rank 
correlation coefficient was -0.72 (significant at 0.01 level). This shows moderate correlation 
however the value is negative as the polarity of scoring is opposite compared to the new 
PROM (Figure 13). The other subdomains of the new PROM showed less correlation 
suggesting a divergent relationship. (Table 18). 
When comparing the body map pain scores against the WOMAC pain score the Spearman’s 
rank correlation was 0.48 (significant at 0.01 level). 
 
Figure 13: Scatter plot for WOMAC and new PROM pain subdomains 
Table 21: Summary of Spearman’s Rank Correlation for pain subdomain and new PROM 
Subdomain Correlation Coefficient Significance Level 
Lower limb function -0.55 < 0.05 
Upper limb function -0.56 < 0.05 
Role limitation -0.54 < 0.05 
Pain and symptoms -0.72 < 0.05 
General health -0.40 < 0.05 






Physical function subdomain 
Three patients were excluded from the analysis (n=57) of the physical function subdomain 
due to incomplete data from WOMAC physical function subdomain. Moderate correlations 
were observed for all the subdomains of the new PROM against WOMAC physical function 
subdomain (Table 19). Scatter plots of this relationship are demonstrated in the following 
figure (Figure 14) . 
 
 






Table 22: Summary of Spearman’s Rank Correlation for physical function subdomain 
Subdomain Correlation Coefficient Significance Level 
Lower limb function -0.73 < 0.05 
Upper limb function -0.65 < 0.05 
Role limitation -0.67 < 0.05 
Pain and symptoms -0.73 < 0.05 






3.4.5.5 SF12 Comparison 
Physical composite summary score 
Sixty patients were included in the comparison analysis for the PCS of the SF12. Spearman’s 
rank correlation coefficients did not show acceptable correlation between the PCS and the 
new PROM subdomains (Table 20). Scatter plots of this relationship with included line of best 
fit are demonstrated in Figure 15 
 






Table 23: Summary of Pearson’s Correlation for SF12 PCS and new PROM 
Subdomain Correlation Coefficient Significance Level 
Lower limb function 0.38 0.003 
Upper limb function 0.30 0.018 
Role limitation 0.37 0.003 
Pain and symptoms 0.27 0.038 






Mental Component Score 
Sixty patients were included in the comparison analysis for the MCS of the SF12. The 
Spearman’s rank correlation coefficients showed moderate correlation for the role limitation 
and general health subdomains, as well as the VAS. There was weak correlation for the lower 
limb function, upper limb function and pain and symptoms subdomains (Figure 16, Table 21). 
 
 
Figure 16: Scatter plots for SF12 MCS against new PROM 
 
Table 24: Summary of Spearman’s Correlation for SF12 MCS and new PROM 
Subdomain Correlation Coefficient Significance Level 
Lower limb function 0.45 < 0.05 
Upper limb function 0.46 < 0.05 
Role limitation 0.58 < 0.05 
Pain and symptoms 0.47 < 0.05 
General health 0.67 < 0.05 






3.4.6 Ceiling and floor effects 
The sample size was 60. With the threshold frequency being set at 15%, nine patients would 
need to enter either the minimum or maximum score for the PROM to exhibit flooring or 
ceiling effects respectively. Only the general health subdomain demonstrated a ceiling effect 
with 21 patients entering the maximum score (35%). When considering the total scores of the 
first 20 questions no floor or ceiling effects were demonstrated. The follow table (Table 22) 
summarises these findings. 
Table 25: Summary of frequencies for maximum and minimum scores 
Subdomain Range Frequencies Effects 
  Minimum (%) Maximum (%)  
Lower limb function 0-24 0 (0) 0 (0) No effects 
Upper limb function 0-20 0 (0) 7 (11.67) No effects 
Role limitation 0-16 2 (3.33) 0 (0) No effects 
Pain and symptoms 0-12 1 (1.67) 0 (0) No effects 
General health 0-8 0 (0) 21 (35) Ceiling effect 






Chapter 4: Discussion 
4.1 Discussion of research methodology 
When considering the project in its entirety both qualitative and quantitative strategies have 
been utilised. This is in line with a mixed method of approach with regards to the study 
methodology. In view of the nature of designing a PROM neither method could have been 
used in isolation to arrive at the end point required. An intimate understanding of the effects 
of OA on a patient could only be explored by analysis of interviews with the recruited patients. 
And validating the new PROM could only be done by employing the previously mentions 
statistical methods.  
In light of this, however, within each stage of the development process the separate research 
methodologies were not combined as such. And in summary stages 1-3 adopted a qualitative 
approach, whilst stage 4 was quantitative. The rest of the discussion will discussion will 






4.2 Discussion for stage 1 
The impact of OA can vary between patients, the experiences in pain, disability and quality of 
life need to be put into the context of that individual (Nyvang, et al., 2016). In order to obtain 
this subjective perspective, it was important to conduct qualitative research by using semi-
structured interviews and analyse the themes yielded from the information obtained. 
This approach is similar to how the OHS and OKS were designed in that 20 patients were 
interviewed initially to obtain a list of themes to be incorporated in their questionnaires 
(Dawson, et al., 1996 and 1998). In this study the initial qualitative interview phase had 50 
patients and it was felt that this increased the range of potential concepts that would be 
discovered. Given the range of patient age (43 – 87) and diversity in the recruited group 
(medical co-morbidities and extent of OA) a variety of activities were listed which 
demonstrates the diverse impact OA can have on individuals. For example, more rare 
activities that were mentioned included having a pedicure and reading books. Whereas the 
most common aspects affected by OA were due to reduced mobility such as walking. 
When the list of themes obtained from this stage are compared with the questions of the 
OHS, OKS and WOMAC there are similarities between the different PROMs (Table 23). 
Although the context in which these themes were asked vary between PROMs the core 
themes are still being represented. This reinforces the fact that there are aspects common to 






Table 26: List of most common theme and relative question found in other PROMs 
New PROM OHS OKS WOMAC 
Theme (Question theme related to) 
Walking Q6 Q4 Q13 
Using stairs (Up or Down) Q7 Q12 Q8,Q9 
Getting in and out of cars Q3 Q3 Q14 
Getting in and out of a bathtub   Q20 
Doing housework Q11 Q9 Q23,Q24 
Standing up from sitting position Q8 Q5 Q10 
Pain Q1, Q10,Q12 Q1, Q8 Q1-5 
Doing shopping Q5 Q11 Q15 
Putting on shoes Q4  Q16 
Getting dressed    
Getting in and out of bed   Q16 
Showering Q2 Q2  
Socialising with friends and relatives    
Kneeling  Q7  
Feeling breathless    
Cold weather affecting pain    
Gardening    
Playing sports    
Carrying things    
Anxiety    
*Total number of questions in OHS and OKS = 12 
**Total number of questions in WOMAC = 24 
 
When considering the list of themes obtained from the qualitative interviews it became 
apparent that they could be placed into certain categories depending on which aspect of the 
patient’s life was affected by OA. To illustrate this, the three activities “playing sports”, 
“walking the dog” and “hiking” could all be categorised as “recreational activities”. This 
creation of categories and refinement of them eventually led to the five subdomains used in 






4.3 Discussion for stage 2 
With regards to perceptions of OA treatment goals there is disparity between patients and 
clinicians (Ramkumar, et al., 2015). Patients would give priority to elimination of symptoms 
and return to physical activity, whereas clinicians prioritise aspects of treatment related to 
treatment safety (Cordero-Ampuero, et al., 2012). Due to this discrepancy, it was felt that 
obtaining the point of view of the clinicians was integral in understanding holistically the 
aspects of treatment of OA in designing the new PROM. 
A representative sample of experts from the different disciplines that manage OA in the 
hospital clinic setting was recruited. Based on qualitative interviews similar themes such as 
pain relief and regaining of function were highlighted to a certain degree. Regarding the new 
themes that were added, these were mainly focused on specific details pertaining to walking. 
From a patient’s point of view, it may be enough for them to be able to walk from their front 
door to the bus stop, for example, and it is not so much of a concern about the speed at which 
they get there. As the PROM is mainly designed to assess these issues from the patient 
perspective, it was felt that questions should be more focused on the practical aspects of 
physical function rather than the technical. 
From the iterative rounds for ranking the themes to be included in the questionnaire only 
“standing on tip toes” was removed for having a low ranking. This indicated that the 
remaining themes were viewed as being relevant when it came to assessing the level of 
function of a patient with OA. With a final count of 70 themes in the item bank after this stage, 
it was felt that the research team had comprehensively investigated aspects relating to 




4.4 Content validity 
The COSMIN study design checklist was used to evaluate the methodological design in 
creation of the new PROM. The checklist is included in Appendix A. It was felt that this study 
adhered to the recommendations well according to their four-point marking scale. The design 
requirements and the score assigned based on this project’s research methodology are 
summarised in the follow table (Table 24). It was felt that Content validity of the new PROM 
was confirmed based on the fact that the questions included in the PROM were relevant to a 
patient suffering from OA of the lower limb. 
Table 27: List of design requirements from COSMIN checklist and score assigned 
Content validity recommendations Score assigned 
Design requirements  
Use appropriate method to assess relevance, 
comprehensiveness and comprehensibility of PROM from 
perspective of patient 
Very good 
Use appropriate method to assess relevance and 
comprehensiveness of PROM from perspective of 
professionals 
Very good 
Include professionals from all relevant disciplines Very good 
Evaluate each item in an appropriate number of patients or 
professionals 
Very good 
Use skilled interviewers Adequate 
Base interviews on interview guide Very good 
Record and transcribe interviews Adequate 
Analyses  
Use appropriate approach to analyse data Very good 
Involve at least two researchers in the analysis Very good 
 
Only adequate scores were obtained for skilled interviewers and recording and transcribing 
of the interviews. This was due to the lack of experience and formal training of the researchers 
and the interviews were not transcribed verbatim. To mitigate this limitation a robust 




4.5 Discussion for stage 3 
4.5.1 Questionnaire length 
The first consideration in formulating the questionnaire was the number of questions to be 
included. Although there is an association between questionnaire length and respondent 
burden one needs to consider the context of the questions included as well (Rolstad, et al., 
2011). It was decided that 20 questions from the item bank would be ideal as this would fit 
on one page of A4 paper with the overleaf containing the body map and VAS questions. 
Although this would essentially make the new PROM “longer” than the OHS for example, the 
OHS is often combined with other questionnaires like the SF-12 therefore increasing the total 
length of all questionnaires that need to be completed by the patient. 
In the context of collecting data for the NJR a patient would be given the OHS or OKS, SF-12, 
EQ-5D and WOMAC to complete in one sitting. This would amount to 6 or 7 pages of questions 
depending on layout. Iglesias and Togerson (2000) was able to conclude that increasing the 
number of pages from 5 to 7 reduces response rates for mailed questionnaires. If the new 
PROM were to be validated for this purpose, theoretically, the burden on the patient based 
on length of questionnaire can be reduced significantly. 
4.5.2 Questionnaire design 
The format and design of the first 20 questions was in such a way as to allow for it to be simple 
and intuitive for the patient to answer. The first 15 questions containing the lower limb, upper 
limb and role limitation domains followed the same format, allowing patients to provide 
perceptions on their level of function (Figure 17). For the pain subdomain the instructions 
were intended to be clear to allow patient to indicate level of pain at rest, and how pain limits 




whether or not a patient’s functional limitation is affected by other factors apart from their 
symptoms due to OA, for example being out of breath limiting the ability to climb stairs 
(Figure 19).  
 
Figure 17: Questions 1-15 of the new PROM using the same format 
 
 








Figure 19: Questions 19 and 20 assessing general health and mood 
 
The Likert scale was chosen as the rating scale for this PROM because if withs widespread use 
and familiarity (Bishop & Herron, 2015). And by having five closed ended responses the 
patient will be obliged to select the option that best fits their opinion. Also, each response of 
the Likert scale can be given a numerical value which can then be used for statistical analysis. 
Despite this however, Rensker et al (2018) showed that a VAS is the preferred rating scale 






4.5.3 Item inclusion 
In the lower limb subdomain, the six items selected were intended to assess composite 
functions that would require the use of the whole limb to perform that activity. The items 
included all scored well during stage 2. Although “getting in and out a bath tub” scored high, 
it was decided that this question would be excluded as in terms of context not all patients 
would use a bath tub to bath and this item might be a potential left unanswered. “Getting in 
and out of bed” was also an item that received high scores however the composite movement 
of getting out of bed arguably includes the upper limb and back as well, therefore this item 
was reconsidered for the role limitation subdomain, but in view of the number of items 
already selected was ultimately left out. 
In the upper limb subdomain, the items included aimed to assess five global functions of the 
upper limb which are required for daily activity. The item “carry things” aimed to assess 
overall arm strength. “Do up buttons” was included to assess patient’s fine motor 
movements. With the “reach for something at shoulder height” item the aim was to assess 
shoulder function as bringing the arm to at least shoulder height is important to allow patients 
to hand clothing, pick up objects from shelves and provide access to under the arm during 
bathing. The “Turn a key” and “Prepare a meal” items were intended to assess other different 
functional grips that the patient use during day to day activity. Although patients with OA of 
the upper limb were not included in the study population there are several PROMs for related 
to upper limb function (Smith, et al., 2012). As we have already established the importance 
of the kinetic chain, it was felt that dedicating a portion of the PROM to upper limb function 




For the role limitation subdomain this included items which pertained to patient’s daily 
activity in society and other complex daily activities. In agreement with Theis et al (2013), it 
was felt that social interaction was also an important aspect of daily function that could be 
affected by OA and that performing one’s job or going for leisure activities would reflect this. 
With regards to “do housework” and “go shopping on my own”, these items would help assess 
patients’ level of independence as these are daily activities which would require overall good 
function to perform. 
The pain and general health subdomains were subdomains with fewest items, three and two 
respectively. As we are already aware, pain is a common symptom in OA and can cause 
limitation in function therefore it was important to include questions that elicit this in the 
new PROM. As for the general health subdomain the aim was to ascertain whether medical 
health or mood were factors that affected a patient’s level of function. These questions were 
included with examples to illustrate that the causes of the limitation in function may not solely 
be related to OA (World Health Organisation, 2020). Invariably a patient could have low mood 
due to the fact that they are severely limited in their activities, this was the reason why it was 
felt a question assessing a patient’s level of satisfaction (the VAS) would be useful. 
4.5.4 Body map 
As the new PROM was designed to assess overall function, it could potentially be applied to 
a patient with OA in any joint. In terms of a PROM being a data collection tool, having an 
objective record of where the patient had pain built into the PROM has potential uses. It 
allowed the patient to conceptualise which joints caused the most problems and from the 
point of view of the clinician it provides an idea to the degree of severity of joints affected “at 




to the first 20 questions to the joints affected by OA. For example, if the patient scored low 
on the lower limb subdomain only and then indicated a majority of the joints in the lower 
limb as being painful, this would confirm that pain from OA largely contributed to the loss of 
function. 
4.5.5 VAS 
The VAS was included to assess the patient’s level of satisfaction with their level of function. 
Information obtained from this question would be useful to the clinician to assess whether 
an intervention was beneficial to the patient. In theory, a THR would eliminate patient’s pain 
coming from the hip and if mobility improved then so would their level of satisfaction. How 
recent a recent study has shown that although patient satisfaction does improve follow THR, 
there was only modest corellation between satisfactions scores and both the OHS and EQ-5D 
(Maillot, et al., 2020). 
A VAS from 0 – 100 was used instead of a Likert type response to allow the patient to have 






4.6 Discussion for stage 4 
4.6.1 Internal consistency 
Interpretation of Cronbach alpha’s needs to be done with caution as without looking into the 
context of the items of the subdomain, incorrect assumptions can be drawn from these values 
(Gardner, 1995). Calculation of Cronbach’s alpha of the first 20 questions revealed an alpha 
value much higher that any of the individual subdomains. This could signify that although 
there are five subdomains proposed during questionnaire design there may still be a degree 
of interrelatedness between the subdomains. Conversely this may be as a result of the fact 
that Cronbach’s alpha is also sensitive to the number of items used to calculate it (Sijtsma, 
2009). This phenomenon has also been reported in another development study of a 
questionnaire (Tuan, et al., 2005). Certainly, interpretation of Cronbach’s alpha is more useful 
when considering individual subdomains (Taber, 2018). 
The Cronbach’s alpha for each of the other subdomains were acceptable (>0.70) apart from 
the pain and symptoms subdomain. When items were deleted from the subdomain and alpha 
calculated there was only one observed increase in Cronbach’s alpha and that was for “carry 
things” question in the upper limb function subdomain. Arguably, the increase was marginal 
with an increase from 0.87 to 0.89, this could suggest that carrying things does not match well 
with the other items in measuring upper limb function. 
With the pain and symptoms subdomain the Cronbach’s alpha was 0.52. This is likely because 
the items included in this subdomain asked questions about pain in two difference 
circumstances; when patient is at rest and when they need to use their arms or legs. In this 
regard a myriad of combinations could be possible for each individual within the extent of 




however experience very little pain at rest. Alternatively, severe pain at rest might preclude 
patient from using the affected limb altogether. This may not necessary be a weakness in 
design as from the clinical point of view both facets of pain symptoms are important to elicit 
from the patient. The interpretation of Cronbach’s alpha may suggest that the pain 
subdomain does have weakened internal consistency compared to the other subdomains in 
the PROM (Tavakol & Dennick, 2011). 
Given that overall the Cronbach’s alpha for the other subdomains were acceptable, when it 
comes to considering the total scores of the subdomain it can assumed that the subdomain 
measures a singular construct. When it comes to assessing correlations with other established 
PROMs, to confirm criterion validity, then using the total scores of the subdomains can be 
done with a degree of confidence. 
It is worth noting that based on the COSMIN checklist it is recommended that >100 patients 
be used to calculate internal consistency to get a “very good” score for statistical analysis. The 
recruitment of 60 patients for this part of the study fell under the next best category, 50 – 99 
patients, providing a score of “adequate”. 
4.6.2 Test-retest reliability 
Thirteen patients did not return the second PROM which was given to them during 
recruitment. This meant that there was a response rate of 78.33%. Unreturned PROMs were 
treated as missing data and a decision needed to be made on how to deal with this. As data 
from the whole questionnaire was missing, techniques to replace these missing values would 
not be possible and these pairs were excluded from the analysis, thus reducing the sample 




With the data that was available, ICC was calculated with the two-way mixed effects with 
absolute agreement model for ICC. This model was used at the patient was taken as an 
individual rater performing the same “test” (the new PROM) twice at different instances (Koo 
& Li, 2016). The ICC obtained for each item in the questionnaire showed good test-retest 
reliability with all items, except question number 18, having ICC value at least >0.70. Question 
number 18 asked a patient about how pain would limit their overall function when trying to 
use their arms and had an ICC coefficient score of 0.61 which still shows moderate reliability. 
Overall, for a recall period of 48hrs, it was felt that the overall ICC scores for each item were 
good and therefore demonstrated that the PROM was reliable in terms of its test-retest 
reliability.  However, due to the loss of data and lower number of patients based on COSMIN 
recommendations, statistical validation of reliability was scored as “doubtful” only. 
4.6.3 Criterion validity 
Exploratory analysis of the data from the new PROM suggested that the data obtained was 
not normally distributed. Furthermore, as the responses were based on an ordinal scale by 
design the data could not be treated as continuous data. The application of numerical scores 
to each response was done to allow for statistical assessment. Based on these reasons it was 
decided that non-parametric tests would be used. 
As was already established in the introduction there is no gold standard to measure what the 
new PROM would like to measure and therefore correlations were made against the PROMs 
which are mainly used in orthopaedic practise. As data from the OHS, OKS, WOMAC and SF12 
would be collected as a matter of routine during clinic visits the additional burden to the 






There is limited evidence in the literature for justification on the ideal sample size, however a 
minimum of 100 patients is ideal of exploratory factor analysis (Anthoine, et al., 2014). During 
the recruitment of patients for this stage of the project only 60 patients were recruited. 
Initially it was overlooked that patients who attended clinic for hip OA would not complete 
the OKS, and the converse was also true. Because of this, comparisons with the OHS and OKS 
were further limited as approximately half the patients recruited attended for hip OA (n=27) 
and the rest attended for knee OA (n=33). This divide did not affect comparisons with 
WOMAC or the SF12 as all patients completed these PROMs regardless of joint affected by 
OA. 
Currently, there is no recognised gold standard for measuring level of physical function or 
outcomes following joint arthroplasty. More recent PROMs that have been developed will 
frequently use the more established WOMAC and Oxford Scores for comparison, for example 
the Knee injury and Osteoarthritis Outcome Score (KOOS) (Roos & Toksvig-Larsen, 2003) and 
the Forgotten Joint Score (Behrend, et al., 2012). Typically, the psychometric criteria of each 
PROM would be evaluated and compared. Correlations between the new PROM and the 
established ones would be performed to measure criterion validity. This project has adopted 
the same approach to satisfy criterion validity. 
OHS correlations 
As a measure of physical function, the new PROM showed good correlations with the OHS. 
This would suggest that the new PROM was able to measure similar concepts that were being 
measured by the OHS (namely pain and physical function). Interestingly better correlation 





The correlations with the OKS were strongest for the lower limb function, role limitation and 
pain and symptoms subdomain of the PROM. As the OKS was designed to assess pain and 
function of patients with OA in the context of having a joint replacement, correlating well in 
these subdomains lends credit to the new PROM being able to similarly measure these 
concepts. The upper limb function subdomain did have moderate correlation as a measure of 
function, but it would be expected to be less compared to the lower limb subdomain. As for 
the general health subdomain this showed weak correlations which may suggest a more 
divergent quality. 
WOMAC 
The WOMAC was spilt into its pain and physical function subdomains for analysis. All the 
subdomains and the body map were compared and there was moderate correlation for the 
pain subdomains. When compared to the physical function subdomain there was moderate 
correlations for all of the subdomains of the new PROM. The correlation analysis with the 
WOMAC suggested that there were at least moderate correlations across the subdomains of 
the new PROM. Given that the WOMAC is a disease specific PROM having moderate 
correlation with the new PROM would suggest that it can be used to assess patients suffering 
from OA. 
SF12 
It was found that there was poor correlation for all subdomains when compared to the PCS. 
The correlations for the MCS were also relatively weak compared to the OHS, OKS and 
WOMAC. The reason for the poorer correlations is likely to be because the PCS and the MCS 




the SF36. Because of this the subdomains of the new PROM were likely to be measuring 
dissimilar concepts compared to the SF12. 
4.6.4 Ceiling and floor effects 
Ceiling and floor effects of the OHS were investigated by Lim et al (2015), and it was concluded 
that the OHS did not exhibit any ceiling or floor effects based on overall scores. On testing the 
overall data this study sample, no floor effects were observed. And the only ceiling effect 
observed was from the general health subdomain. Twenty-one patients (35%) reported full 
scores for this subdomain.  When interpreting this subdomain, a maximum score would 
indicate that the patients were not limited in their physical function by other medical issues 
or their mood. When considering this as a “true” ceiling effect it needs to be viewed in the 
context of how the patient would answer the rest of the questionnaire. As the new PROM is 
designed to assess physical function of patients with OA, a certain degree of limitation may 
be due to other factors apart from symptoms from OA, but there will be a proportion of 
patients who are free from other co-morbidities that could cause functional limitations. 
However, when the overall score of the first 20 questions of the new PROM are considered, 
there were no floor or ceiling effects. In this regard, when considering the new PROM in its 
entirety, could be suggested that the PROM is able to measure the full spectrum of physical 
function in patients suffering from OA (from completely able to completely disabled) as the 
lack of floor or ceiling effects would mean that there is enough range within the questionnaire 





4.7 Meeting project objectives 
The objectives of this project were met with the creation of the new PROM. The initial 
population was defined as adult patients who suffer from OA of the lower limb. Patients were 
then recruited from this population for the different stages of questionnaire development. A 
representative group of patients were interviewed to obtain a list of themes which were 
investigated and included in an item bank. 
An expert panel was successfully recruited for the second stage of questionnaire 
development. Opinions of the expert panel were recorded through semi-structured 
interviews. Questionnaires were used to allow the expert panel to rank items according to 
relevance. The items that were ranked satisfied content validity and would later be used to 
build the new PROM. 
The PROM was created successfully from the item bank, the body map, and the VAS. The 
questionnaire was then assessed by another group of patients to qualitatively assess its 
design and content. Following this, minor revisions were done, and the final version of the 
new PROM was created. 
Lastly a final group of patients were recruited to perform quantitative analysis to validate the 
questionnaire. Measurement properties that were validated include: internal consistency, 






4.9 Project limitations 
There are several limitations in this project. 
The first limitation was that the number of patients recruited was less than 100. For any 
validation study it is recommended that there be at least 100 patients in order to increase 
statistical power. Due to this limitation, conclusions drawn from any quantitative analyses 
must be acknowledged as being made in light of this limitation. However, as this is a 
preliminary study to assess the measurement properties of a newly developed PROM, the 
results can still be taken to demonstrate the potential of it having robust psychometric 
criteria. 
Another limitation is that the subdomains created, and the items included in each, were based 
of categories selected by pooling together common themes derived from the qualitative 
interviews with the recruited participants. Ultimately the selections were made at the 
discretion of the research team, albeit adhering to PROM development recommendations, 
and there will be an inherent weakness as the subjective opinions of the research team cannot 
completely be eliminated. If more patients were recruited, then exploratory factor analysis 
and confirmatory factor analysis could have been potential techniques used to identify 
subdomains and reduced the number of items. 
A further limitation was the body map question. The method selected to assess criterion 
validity for this question was to use it as a substitute for a pain score and try to correlate it 
against other pain subdomains in other PROMs. The research team felt that this was the next 
best method to provide an attempt to validate it ensure that it assess what it was intended 
to. As the use of a body map is a novel concept for PROMs related to OA its potential use will 




4.10 Further work 
There is scope for further work with the development of this new PROM. Due to the limited 
number of patients recruited, work from this project can be treated as a pilot study for further 
validation studies on a larger scale. Furthermore, a psychometric criterion which has not been 
investigated in this project was the sensitivity to detect change, and by extension, in the 
clinical setting the minimum clinical important difference (MCID). To do this, data before and 
after an intervention needs to be collected. In the context of OA, joint replacement surgery 
would be the ideal intervention to use as it has been proven to provide life changing benefit 
to the patient. Assessing sensitivity to change was beyond the scope of this project, but 
potential further work in this area is justified to completely validate the PROM and to detect 





Chapter 5: Conclusion 
The completion of this project has led to the development of a new PROM for patients with 
OA that assesses the overall level of function. The population that the PROM should be used 
for has been clearly defined and evaluation of the themes measuring overall function have 
been undertaken in this same patient group. Through qualitative interviews and obtaining 
expert opinion the PROM has been developed from a list of items that satisfy content validity. 
The prototype of the questionnaire has been assessed qualitatively and has been found to be 
suitable by the target population. 
Analysis of the new PROM has shown acceptable internal consistency across its subdomains 
and good test-retest reliability. On testing for criterion validity, it has demonstrated moderate 
correlations with the OHS and OKS, two of the most used joint specific PROMS, and the 
WOMAC, a well validated disease specific PROM. 
Although this new PROM shows some promise the work outlined in this project only 
constitutes to preliminary study aimed to assess the viability of using such a PROM as a 
replacement or supplement to the more established and well-studied PROMs. Further work 
is required to fully validate the new PROM before it can be used in the general population. 
The PROM needs to be validated on a wider scale, sensitivity to detect change needs to be 

















































































































































































Appendix O: Most frequent themes identified from stage 1 
Item description Frequency from qualitative analysis, N(%) 
Walking 41(82) 
Using stairs (Up or Down) 24(48) 
Getting in and out of cars 19(38) 
Getting in and out of a bathtub 16(32) 
Doing housework 16(32) 
Standing up from sitting position 14(28) 
Pain 14(28) 
Doing shopping 12(24) 
Putting on shoes 11(22) 
Getting dressed 9(18) 
Getting in and out of bed 8(16) 
Showering 7(14) 
Socialising with friends and relatives 7(14) 
Kneeling 7(14) 
Feeling breathless 6(12) 
Cold weather affecting pain 6(12) 
Gardening 6(12) 
Playing sports 5(10) 












Item Domain n Median Mean sds 95 % CI Concensus?
Getting In and out of bed (5.14) Lower l imb function 10 5.00 5.20 0.63 4.81 - 5.59 Yes
Getting In and out of bath (4.57) Lower l imb function 10 5.00 5.00 0.67 4.59 - 5.41 Yes
Getting In and out of shower (5.07) Lower l imb function 10 5.00 5.30 0.67 4.88 - 5.72 Yes
Dressing: Pulling up Trousers (4.93) Lower l imb function 10 5.00 4.50 1.08 3.83 - 5.17 No
Dressing: Putting on footwear (new) Lower limb function 10 6.00 5.70 0.48 5.40 - 6.00 Yes
Climbing up one fl ight of stairs (5.50) Lower l imb function 10 5.00 5.20 0.92 4.63 - 5.77 Yes
Going down one fl ight of stairs (5.43) Lower l imb function 10 5.00 5.20 0.92 4.63 - 5.77 Yes
Going up and down one fl ight of stairs (4.93) Lower l imb function 10 5.00 4.40 1.43 3.51 - 5.29 Yes
Get in and out of car (5.29) Lower l imb function 10 5.00 5.10 0.57 4.75 - 5.45 Yes
Get on and off bus (4.57) Lower l imb function 10 5.00 4.90 1.10 4.22 - 5.58 Yes
Walking on flat surface (5.57) Lower l imb function 10 6.00 5.60 0.70 5.17 - 6.03 Yes
Stand up from sitting position (5.86) Lower l imb function 9 6.00 5.89 0.33 5.67 - 6.11 Yes
Kneeling down and getting back up (4.86) Lower l imb function 10 4.50 4.50 0.85 3.97 - 5.03 Yes
Maximum walking distance (5.21) Lower l imb function 10 6.00 5.60 0.52 5.28 - 5.92 Yes
Walking on uneven surface (5.07) Lower l imb function 10 5.00 5.00 0.47 4.71 - 5.29 Yes
Walking with aids (5.50) Lower l imb function 10 5.00 5.20 0.92 4.63 - 5.77 Yes
Walking up and down hills (4.57) Lower l imb function 10 4.00 4.20 0.79 3.71 - 4.69 Yes
Squatting (4.71) Lower l imb function 10 4.00 4.10 0.99 3.48 - 4.72 No
Standing for a period of time (5.43) Lower l imb function 10 5.00 5.40 0.52 5.08 - 5.72 Yes
Brushing teeth (5.09) Upper l imb function 9 6.00 5.56 0.53 5.21 - 5.90 Yes
Dressing: Doing up Buttons (5.75) Upper l imb function 9 6.00 5.67 0.50 5.34 - 5.99 Yes
Grooming (comb hair) & Make-up (5.50) Upper l imb function 9 6.00 5.56 0.53 5.21 - 5.90 Yes
Prepare a meal (5.75) Upper l imb function 9 6.00 5.56 0.53 5.21 - 5.90 Yes
Carry a tray (5.25) Upper l imb function 9 5.00 5.33 0.50 5.01 - 5.66 Yes
Turning a key (5.25) Upper l imb function 9 6.00 5.56 0.53 5.21 - 5.90 Yes
Carry shopping bags (5.42) Upper l imb function 9 5.00 5.22 0.83 4.68 - 5.77 Yes
Opening a tight jar (5.17) Upper l imb function 9 5.00 5.00 0.87 4.43 - 5.57 Yes
Reaching for object above head (5.75) Upper l imb function 9 6.00 5.44 0.88 4.87 - 6.02 Yes
Doing Dishes (manually or dishwasher) (5.17) Upper l imb function 9 5.00 5.33 0.71 4.87 - 5.80 Yes
Opening a door (5.50) Upper l imb function 9 6.00 5.56 0.73 5.08 - 6.03 Yes
Reach behind back (5.58) Upper l imb function 9 5.00 5.22 0.44 4.93 - 5.51 Yes
Using keyboard / computer (4.92) Upper l imb function 8 5.50 5.50 0.53 5.13 - 5.87 Yes
Writing (5.58) Upper l imb function 9 6.00 5.33 1.00 4.68 - 5.99 Yes
Picking up small things (e.g. coins, keys etc) (5.67) Upper l imb function 9 5.00 5.44 0.53 5.10 - 5.79 Yes
Lifting things (5.17) Upper l imb function 9 5.00 5.22 0.67 4.79 - 5.66 Yes
Washing self all  over (5.67) Upper l imb function 9 6.00 5.67 0.50 5.34 - 5.99 Yes
Using knife and fork (5.75) Upper l imb function 9 6.00 5.67 0.50 5.34 - 5.99 Yes
Hang clothes (5.33) Upper l imb function 9 5.00 5.11 0.60 4.72 - 5.50 Yes
Cleaning around the house (5.07) Role restriction 10 5.00 5.40 0.52 5.08 - 5.72 Yes
Recreational activities (new) Role restriction 10 5.00 5.20 0.63 4.81 - 5.59 Yes
Ability to do work or daily job (5.57) Role restriction 10 5.50 5.50 0.53 5.17 - 5.83 Yes
Socialising with friends and family (4.86) Role restriction 10 5.00 5.00 0.67 4.59 - 5.41 Yes
Sporting activities or exercise (new) Role restriction 10 5.00 5.30 0.48 5.00 - 5.60 Yes






Level of General physical health (5.64) General health 10 6.00 5.80 0.42 5.54 - 6.06 Yes
General health affecting lower limb function (5.36) General health 10 6.00 5.70 0.48 5.40 - 6.00 Yes
General health affection upper limb function (5.36) General health 10 6.00 5.70 0.48 5.40 - 6.00 Yes
Level of Emotional wellbeing (5.57) General health 10 5.50 5.50 0.53 5.17 - 5.83 Yes
Level of Anxiety (5.64) General health 10 6.00 5.70 0.48 5.40 - 6.00 Yes
Level of Depression (5.57) General health 10 6.00 5.50 0.71 5.06 - 5.94 Yes
Feeling self-conscious (5.07) General health 10 5.00 5.20 0.63 4.81 - 5.59 Yes
Pre-occupied by symptoms (5.21) General health 10 5.00 5.40 0.52 5.08 - 5.72 Yes
Pain Severity (5.93) Pain and symptoms 10 6.00 5.90 0.32 5.70 - 6.10 Yes
Pain Frequency (5.85) Pain and symptoms 10 6.00 5.90 0.32 5.70 - 6.10 Yes
Pain Limiting Lower limb function (5.79) Pain and symptoms 10 6.00 5.90 0.32 5.70 - 6.10 Yes
Pain Limiting Upper limb function (5.79) Pain and symptoms 10 6.00 5.90 0.32 5.70 - 6.10 Yes
Awareness of pain (5.15) Pain and symptoms 10 5.00 5.40 0.52 5.08 - 5.72 Yes
Pain symptoms disturbing sleep (5.79) Pain and symptoms 10 6.00 5.60 0.84 5.08 - 6.12 Yes
Pain during activity (5.71) Pain and symptoms 10 6.00 5.70 0.67 5.28 - 6.12 Yes
Pain at rest (5.93) Pain and symptoms 10 6.00 5.90 0.32 5.70 - 6.10 Yes
Stopping activity because of pain (5.93) Pain and symptoms 10 6.00 5.70 0.48 5.40 - 6.00 Yes
Pre-occupied by pain (5.07) Pain and symptoms 10 5.00 5.40 0.52 5.08 - 5.72 Yes
Worse pain vs Usual pain (5.00) Pain and symptoms 10 5.00 5.20 0.79 4.71 - 5.69 Yes
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